Is there a place for maintenance therapy in extensive stage SCLC?
Article
Drs. Mary Pinder, Nate Pennell, and Jack West discuss whether the finding of improving progression-free survival with maintenance sorafenib for SCLC should change the standard of care for treatment of extensive stage disease.
[powerpress]